tradingkey.logo

Concerned Shareholders Of Aurinia Pharmaceuticals Announce Their Intention To Withhold Support For CEO Peter Greenleaf At 2025 Annual Meeting

ReutersApr 23, 2025 8:58 PM

- Aurinia Pharmaceuticals Inc AUPH.O:

  • CONCERNED SHAREHOLDERS OF AURINIA PHARMACEUTICALS ANNOUNCE THEIR INTENTION TO WITHHOLD SUPPORT FOR CEO PETER GREENLEAF AT 2025 ANNUAL MEETING

  • MARKET CAPITAL AND LUCIEN SELCE: BELIEVE AURINIA SHAREHOLDERS WOULD BENEFIT FROM A LEANER, MORE ACCOUNTABLE BOARD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI